For the breast cancer dataset, the results of the multivariate survival analysis showed that the hazard ratio for the group with a mutation of SLC34A2 gene is 14.42 (CI: 4.24–49.05; Supplementary Figure S1A); the parameters with a higher hazard ratio were Neoplasm Disease Lymph Node Stage N3, Neoplasm Disease Stage III and IV. Here, SLC34A2 is linked to neoplasm.